3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
16
Carcinoma, Non-Small-Cell Lung
8
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
2
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Urothelial Cancer
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Malignancies
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Mesothelioma, Malignant
1
Hypertension, Portal
1
Hydronephrosis
1
Hepato Cellular Carcinoma
1
Hematologic Neoplasms
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
Etoposide
3
Carboplatin
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
Paclitaxel
2
Cyclophosphamide
2
Cisplatin
2
repotrectinib
1
pralsetinib
1
lutetium Lu 177 dotatate
1
Vorinostat
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Gemcitabine
1
Cytapheresis
1
Bleomycin
1
Biopsy
1
Automobiles
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
tremelimumab
×
90 days
×
Clear all
No trials found.